Media ReleasesPhylogica

View All Phylogica News


Phylogica, Investor Presentation: Harnessing Biodiversity for Peptide Therapeutics

Summary

-  Assembled and validated a world-class peptide drug discovery platform.

-  Patent protection on worlds largest source of naturally structured peptides and related screening technologies - priority to 2027.

-  Successfully validated 'Alliance Model' with four top 10 Pharma is 4 years which has generated $5.8M in committed revenue, plus milestones & royalties.

-  Anticipate near-term revenue growth and cash sustainability.

-  Building value through technical enhancements and in-house discovery programs.

-  Peer comparison provides first time indication of potential value.


To view Presentation please download PDF below:

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?